Duchenne muscular dystrophy: pathogenesis and promising therapies

M Chang, Y Cai, Z Gao, X Chen, B Liu, C Zhang… - Journal of …, 2023 - Springer
Duchenne muscular dystrophy (DMD) is a severe, progressive, muscle-wasting disease,
characterized by progressive deterioration of skeletal muscle that causes rapid loss of …

To skip or not to skip: that is the question for duchenne muscular dystrophy.

MJ Wood - Molecular Therapy: the Journal of the American Society …, 2013 - europepmc.org
GSK/Prosensa's failure doesn't represent undiluted good news given that the utility of exon
skipping is in question and the challenge of designing a study to demonstrate clinical …

[HTML][HTML] Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy

V Himič, KE Davies - European Journal of Human Genetics, 2021 - nature.com
Duchenne muscular dystrophy (DMD) is an X-linked progressive muscle-wasting disorder
that is caused by a lack of functional dystrophin, a cytoplasmic protein necessary for the …

Molecular treatments in Duchenne muscular dystrophy

M Guglieri, K Bushby - Current opinion in pharmacology, 2010 - Elsevier
Duchenne muscular dystrophy (DMD) is the most common childhood muscular dystrophy
and results from mutations in the dystrophin gene. Currently no treatment is available for this …

[HTML][HTML] Lessons learned from discontinued clinical developments in Duchenne muscular dystrophy

T Markati, L De Waele, U Schara-Schmidt… - Frontiers in …, 2021 - frontiersin.org
Duchenne muscular dystrophy (DMD) is an X-linked condition caused by a deficiency of
functional dystrophin protein. Patients experience progressive muscle weakness …

[HTML][HTML] Therapeutic strategies for Duchenne muscular dystrophy: an update

C Sun, L Shen, Z Zhang, X Xie - Genes, 2020 - mdpi.com
Neuromuscular disorders encompass a heterogeneous group of conditions that impair the
function of muscles, motor neurons, peripheral nerves, and neuromuscular junctions. Being …

[图书][B] Duchenne muscular dystrophy: advances in therapeutics

JS Chamberlain, TA Rando - 2006 - books.google.com
Duchenne Muscular Dystrophy (DMD) is one of the most prevalent genetic disorders of
childhood for which there is no cure. This authoritative guide provides a clear overview of …

Drug discovery of therapies for duchenne muscular dystrophy

Y Blat, S Blat - Journal of biomolecular screening, 2015 - journals.sagepub.com
Duchenne muscular dystrophy (DMD) is a genetic, lethal, muscle disorder caused by the
loss of the muscle protein, dystrophin, leading to progressive loss of muscle fibers and …

[HTML][HTML] A brief review of Duchenne muscular dystrophy treatment options, with an emphasis on two novel strategies

A Heydemann, M Siemionow - Biomedicines, 2023 - mdpi.com
Despite the full cloning of the Dystrophin cDNA 35 years ago, no effective treatment exists
for the Duchenne Muscular Dystrophy (DMD) patients who have a mutation in this gene …

Progress towards gene therapy for Duchenne muscular dystrophy

MA Hauser, JS Chamberlain - Journal of endocrinology, 1996 - joe.bioscientifica.com
Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by defects in
the dystrophin gene. Patients exhibit progressive muscle degeneration, generally begin …